Back to 
TWO SIGMA INVESTMENTS, LP
TWO SIGMA INVESTMENTS, LP
RNA2 quarters
Position history for TWO SIGMA INVESTMENTS, LP's holdings in ATRIUM THERAPEUTICS INC
TWO SIGMA INVESTMENTS, LP holds 345,481 shares of RNA (ATRIUM THERAPEUTICS INC), worth $4.6M as of 2026-Q2. The position was increased (+93.5% shares). RNA represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.
Current Value
$4.6M
Current Shares
345,481
Total Value Change
+$2.3M
Total Shares Change
+166,921
Quarter-by-Quarter History
Other major holders of RNA: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC